Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Financial Report: Catalent Pharma Solutions



Published September 19, 2007
Related Searches: Financial Reports

Catalent Pharma Solutions

4Q Revenues: $451.3 million (+5%)

4Q Loss: $168.7 million (earnings were $27.6 million 4Q2006)

FY Revenues: $1.7 billion (+6%)

FY Loss: $127.3 million (earnings were $51 million FY2006)

Comments: FY and 4Q revenue growth was primarily driven by the Packaging Services segment, particularly within Europe, as well as from continued strong demand for Zydis products within the Oral Technologies segment. Packaging Services revenue was $138 million in the quarter, up 11% and for the year was $552 million, up 14%. In April 2007, an affiliate of The Blackstone Group acquired the company from Cardinal Health for approximately $3.3 billion.



blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On